Unidade Local De Saude De Almada-Seixal E.P.E. — Clinical Trial Site

92 Registered trials

33 Currently recruiting

Organisation

Unidade Local De Saude De Almada-Seixal E.P.E.

Location

Almada, Portugal

Identifier

ORG-100029370

Address

Avenida Torrado Da Silva, 2805-267, Portugal

Departments

2705: Serviço Cardiologia
2802; Inf. Disease/Infectiology
3105:Cardiologia
3306: Serviço de Dermatologia
9234: Serviço de Dermatologia
Cardiology
Cardiology Department
Department of Cardiology
Department of Pneumology
Dermato-veneorology
Dermatology
Dermatology Department
Hemato-oncologia
Hemato-oncology
Hemato-Oncology Department
Hospital Garcia de Orta, EPE
Hospital Garcia de Orta, EPE(#1)
Medical Oncology
n/a
NA
Nephrology
Neurocirurgia
Neurologia
Neurology
Oncology
Oncology Department
Otorhinolaryngology Department
Pediatria
Pediatric Department
Pneumunology
Pulmonology
Rheumatology
Rheumatology Department
Serviço Cardiologia
Serviço de Cardiologia
Serviço de Hematologia
Serviço de Nefrologia
Serviço de Neurologia
Servico de Oncologia Medica
Serviço de Pediatria (Hospital Garcia de Orta)
Serviço de Reumatologia
Urology

Clinical trials at this site (92)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension 10
A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso… Pending

2025-522586-30-00 Psoriatic Arthritis 5
A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Pending

2025-523425-17-00 Proteinuric kidney diseases 4
AMAZE 8: A research study investigating how well the medicine NNC0487-0111 compared to semaglutide helps people with excess body weight and … Recruiting

2024-520446-31-00 Participants with overweight or obesity, and type 2 dia 5 2026-05-27
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Pulmonary Hypertension associated with interstitial lun 5 2026-04-21
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
Phase 1b/2a clinical trial to determine the safety, tolerability and efficacy of TZ-161 in Spinal Cord Injury Recruiting

2023-509207-33-01 Early acute spinal cord injury 9 2025-07-09
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized cli… Recruiting

2024-514732-24-00 Juvenile idiopathic arthritis 6 2025-04-28
A phase 3 multi-center trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroids in children (ag… Recruiting

2023-503630-44-00 Treatment of moderate-to-severe Atopic dermatitis 10 2024-11-20
A study of different investigational treatments in people with the interstitial lung disease that accompanies scleroderma (CONQUEST) Recruiting

2023-507129-40-00 interstitial lung disease secondary to systemic scleros 4 2024-08-06
Long-term Extension Study to Assess Adverse Events and Tolerability of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Ag… Recruiting

2022-501099-24-00 Migraine 5 2023-12-22
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
A Long-term Follow-up Study of Sotatercept for PAH Treatment Recruiting

2023-509138-21-00 Pulmonary Arterial Hypertension (PAH) 5 2021-08-26
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus E… Recruiting

2025-523552-31-00 Systemic Lupus Erythematosus 5 2026-05-07
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), compared with Topotecan in… Recruiting

2025-521627-78-00 Neoplasms, Lung 5 2026-01-28
A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-11-28
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting

2024-513613-12-00 Part A: Healthy volunteers (Part A is not applicable to 9 2025-09-18
Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION) Recruiting

2024-519521-37-01 Acute ischemic stroke 10 2025-07-30
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17